AMINOLEVULINIC ACID HYDROCHLORIDE

AMINOLEVULINIC ACID HYDROCHLORIDE was reported 1746 times

AMINOLEVULINIC ACID HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PHOTODYNAMIC THERAPY 1 0.1429
1 APPLICATION SITE DYSAESTHESIA 1 0.1250
2 ANNULAR ELASTOLYTIC GIANT CELL GRANULOMA 1 0.1000
3 APPLICATION SITE STREAKING 1 0.0769
4 SYSTEMIC VIRAL INFECTION 1 0.0714
5 MEDICAL DEVICE SITE BURN 1 0.0455
6 MEDICAL DEVICE SITE ODOUR 1 0.0357
7 DEFORMITY OF ORBIT 1 0.0323
8 ORBITAL HAEMATOMA 1 0.0294
9 APPLICATION SITE PHOTOSENSITIVITY REACTION 1 0.0270
10 APPLICATION SITE PUSTULES 7 0.0192
11 PACKAGING DESIGN ISSUE 6 0.0182
12 POOR QUALITY PRODUCT ADMINISTERED 177 0.0168
13 PSEUDOFOLLICULITIS 1 0.0159
14 VIRAL SEPSIS 2 0.0143
15 BURNS FIRST DEGREE 4 0.0140
16 EYE BURNS 8 0.0136
17 ROSEOLA 1 0.0123
18 ADMINISTRATION SITE OEDEMA 1 0.0116
19 APPLICATION SITE FISSURE 1 0.0111
20 ADMINISTRATION SITE DISCOMFORT 2 0.0106
21 CEREBROSPINAL FLUID RETENTION 1 0.0085
22 ADMINISTRATION SITE DISCOLOURATION 1 0.0080
23 TRANSIENT APHASIA 1 0.0076
24 ADMINISTRATION SITE ERYTHEMA 2 0.0070
25 OROPHARYNGEAL OEDEMA 1 0.0069
26 LIMB IMMOBILISATION 1 0.0054
27 BLOOD KETONE BODY PRESENT 1 0.0053
28 EXPOSURE TO EXTREME TEMPERATURE 1 0.0052
29 METASTASES TO SPINAL CORD 1 0.0052
30 BRAIN TUMOUR OPERATION 1 0.0050
31 MANUFACTURING MATERIALS ISSUE 2 0.0050
32 PERIORBITAL DISORDER 1 0.0049
33 MANUFACTURING ISSUE 2 0.0043
34 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 1 0.0042
35 PRODUCT PACKAGE ASSOCIATED INJURY 9 0.0040
36 LIQUID PRODUCT PHYSICAL ISSUE 29 0.0040
37 APPLICATION SITE INFECTION 2 0.0039
38 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
39 OVERGROWTH BACTERIAL 1 0.0037
40 CHEMICAL BURN 4 0.0035
41 ADMINISTRATION SITE PAIN 4 0.0035
42 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 2 0.0033
43 APPLICATION SITE SCAB 7 0.0032
44 PRODUCT DEPOSIT 5 0.0032
45 CHALAZION 2 0.0031
46 APPLICATION SITE OEDEMA 1 0.0031
47 ADMINISTRATION SITE SWELLING 1 0.0031
48 PRODUCT PHYSICAL ISSUE 62 0.0031
49 CNS VENTRICULITIS 1 0.0031
50 PNEUMOCEPHALUS 1 0.0030
51 APPLICATION SITE SWELLING 15 0.0030
52 PRECANCEROUS CONDITION 2 0.0030
53 TYPE IV HYPERSENSITIVITY REACTION 7 0.0026
54 NONSPECIFIC REACTION 14 0.0025
55 RASH MORBILLIFORM 7 0.0025
56 PRODUCT LEAKAGE 14 0.0025
57 APPLICATION SITE EXFOLIATION 10 0.0024
58 APPLICATION SITE LACERATION 1 0.0024
59 FEEDING INTOLERANCE 1 0.0022
60 SKIN WRINKLING 6 0.0022
61 SUSPECTED COUNTERFEIT PRODUCT 8 0.0020
62 APPLICATION SITE VESICLES 13 0.0020
63 APPLICATION SITE REACTION 14 0.0020
64 CAPILLARY FRAGILITY 1 0.0020
65 APPLICATION SITE PAIN 42 0.0019
66 INSTILLATION SITE ERYTHEMA 1 0.0019
67 APPLICATION SITE PAPULES 2 0.0019
68 SUNBURN 14 0.0019
69 EPHELIDES 1 0.0019
70 COLLAGEN DISORDER 1 0.0017
71 OPTIC NERVE INJURY 2 0.0017
72 APPLICATION SITE DISCOLOURATION 7 0.0017
73 BURNS SECOND DEGREE 3 0.0017
74 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
75 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 1 0.0017
76 ALLERGY TO METALS 1 0.0016
77 APPLICATION SITE BURN 8 0.0016
78 DERMATOSIS 1 0.0016
79 PERIORAL DERMATITIS 1 0.0016
80 NECROTISING RETINITIS 1 0.0016
81 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
82 DACRYOSTENOSIS ACQUIRED 2 0.0015
83 WRONG DEVICE USED 1 0.0015
84 PHOTOSENSITIVITY REACTION 25 0.0015
85 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
86 DERMATITIS ACNEIFORM 9 0.0015
87 KERATOACANTHOMA 1 0.0015
88 DEVICE ELECTRICAL FINDING 1 0.0014
89 PRODUCT DESIGN ISSUE 1 0.0014
90 TRANSIENT GLOBAL AMNESIA 1 0.0014
91 LACERATION 13 0.0014
92 PRECANCEROUS SKIN LESION 2 0.0014
93 BLISTER RUPTURE 1 0.0013
94 APPLICATION SITE ERYTHEMA 35 0.0013
95 PRODUCT CONTAINER ISSUE 11 0.0013
96 PUSTULE 3 0.0013
97 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
98 DYSCHROMATOPSIA 1 0.0012
99 PRODUCT QUALITY ISSUE 153 0.0011
100 SKIN WEEPING 4 0.0011
101 SKIN DISCOMFORT 3 0.0011
102 PUNCTATE KERATITIS 1 0.0011
103 PRODUCT APPEARANCE CONFUSION 1 0.0011
104 PHARYNGEAL HYPOAESTHESIA 1 0.0011
105 SKIN TEXTURE ABNORMAL 1 0.0010
106 TELANGIECTASIA 1 0.0010
107 APPLICATION SITE BRUISE 1 0.0010
108 BLEPHARITIS 4 0.0010
109 EYE COLOUR CHANGE 1 0.0010
110 SPONTANEOUS HAEMORRHAGE 1 0.0010
111 SKIN SENSITISATION 1 0.0010
112 DEVICE OPERATIONAL ISSUE 4 0.0009
113 PRODUCT NAME CONFUSION 1 0.0009
114 SUPERFICIAL INJURY OF EYE 1 0.0009
115 PRODUCT PHYSICAL CONSISTENCY ISSUE 5 0.0009
116 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 182 0.0009
117 BLISTER 50 0.0009
118 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
119 PHOTOPHOBIA 16 0.0008
120 HYPERTENSIVE EMERGENCY 1 0.0008
121 DEVICE DISPENSING ERROR 1 0.0008
122 RASH VESICULAR 4 0.0008
123 PRODUCT PACKAGING CONFUSION 2 0.0008
124 HAEMATOCRIT ABNORMAL 1 0.0008
125 PIGMENTATION DISORDER 5 0.0008
126 APPLICATION SITE SCAR 1 0.0008
127 LIP DISCOLOURATION 1 0.0008
128 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
129 APPLICATION SITE WARMTH 1 0.0008
130 ACCIDENTAL EXPOSURE TO PRODUCT 80 0.0008
131 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
132 HERPES OPHTHALMIC 1 0.0008
133 OFF LABEL USE OF DEVICE 1 0.0007
134 SKIN LACERATION 8 0.0007
135 LIP BLISTER 2 0.0007
136 APPLICATION SITE HAEMORRHAGE 2 0.0007
137 MENINGITIS VIRAL 1 0.0007
138 HYPERKERATOSIS 4 0.0007
139 APPLICATION SITE INFLAMMATION 1 0.0007
140 MENINGITIS BACTERIAL 1 0.0007
141 PORPHYRIA ACUTE 1 0.0007
142 VASCULAR INJURY 1 0.0007
143 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
144 DARK CIRCLES UNDER EYES 1 0.0007
145 APRAXIA 1 0.0007
146 KERATITIS 2 0.0007
147 EYE ALLERGY 1 0.0006
148 URINE KETONE BODY PRESENT 1 0.0006
149 PRODUCT PACKAGING ISSUE 6 0.0006
150 SCAB 7 0.0006
151 APPLICATION SITE DRYNESS 2 0.0006
152 GLIOBLASTOMA 1 0.0006
153 TREATMENT DELAYED 1 0.0006
154 DEVICE DEFECTIVE 10 0.0006
155 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
156 VERTIGO POSITIONAL 1 0.0006
157 EMBOLIC STROKE 2 0.0006
158 SKIN HYPOPIGMENTATION 1 0.0006
159 LACRIMATION INCREASED 17 0.0006
160 FACIAL PAIN 5 0.0006
161 APPLICATION SITE DISCOMFORT 1 0.0006
162 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
163 NASAL OEDEMA 1 0.0006
164 PRODUCT COMPLAINT 14 0.0006
165 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
166 PRODUCT ADMINISTRATION ERROR 11 0.0005
167 NASAL OBSTRUCTION 1 0.0005
168 ERYTHEMA 106 0.0005
169 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
170 EYE IRRITATION 29 0.0005
171 DERMATITIS PSORIASIFORM 1 0.0005
172 THERAPY NON-RESPONDER 21 0.0005
173 EXOPHTHALMOS 1 0.0005
174 CORNEAL DISORDER 1 0.0005
175 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
176 PRODUCT COMMUNICATION ISSUE 4 0.0005
177 PRODUCT LABEL ISSUE 3 0.0004
178 EYELID DISORDER 1 0.0004
179 EYE SWELLING 16 0.0004
180 ROSACEA 2 0.0004
181 SINUS PAIN 1 0.0004
182 SKIN TIGHTNESS 2 0.0004
183 SKIN EXFOLIATION 35 0.0004
184 BURNING SENSATION 29 0.0004
185 RASH PUSTULAR 3 0.0004
186 VITREOUS FLOATERS 4 0.0004
187 RETINAL TEAR 1 0.0004
188 PRODUCT DOSE OMISSION ISSUE 114 0.0004
189 PRODUCT USE COMPLAINT 6 0.0004
190 SCRATCH 4 0.0004
191 TRICHORRHEXIS 1 0.0004
192 OCULAR DISCOMFORT 4 0.0004
193 NEUTROPHIL COUNT ABNORMAL 1 0.0004
194 DERMATITIS CONTACT 4 0.0004
195 SKIN HYPERPIGMENTATION 3 0.0003
196 VOMITING PROJECTILE 1 0.0003
197 TOOTH DISCOLOURATION 1 0.0003
198 SWELLING FACE 22 0.0003
199 HYPERCAPNIA 1 0.0003
200 ACNE CYSTIC 1 0.0003
201 SWELLING OF EYELID 2 0.0003
202 PHOTOPSIA 2 0.0003
203 RASH MACULO-PAPULAR 7 0.0003
204 FOREIGN BODY SENSATION IN EYES 2 0.0003
205 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
206 TREATMENT FAILURE 25 0.0003
207 EYE PAIN 17 0.0003
208 THERMAL BURN 2 0.0003
209 SENSITIVE SKIN 2 0.0003
210 ALCOHOL USE 1 0.0003
211 AMYLASE INCREASED 1 0.0003
212 APPLICATION SITE PRURITUS 6 0.0003
213 FACE INJURY 1 0.0003
214 WOUND SECRETION 1 0.0003
215 SKIN BURNING SENSATION 18 0.0003
216 HAIR COLOUR CHANGES 3 0.0002
217 BRAIN OEDEMA 3 0.0002
218 BUNDLE BRANCH BLOCK LEFT 1 0.0002
219 PRODUCT DISPENSING ISSUE 1 0.0002
220 SCAR 4 0.0002
221 SKIN SWELLING 2 0.0002
222 CHAPPED LIPS 1 0.0002
223 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
224 SUSPECTED OFF LABEL USE 1 0.0002
225 DRY EYE 11 0.0002
226 DRUG INEFFECTIVE 290 0.0002
227 SHOCK 5 0.0002
228 THERAPEUTIC RESPONSE DECREASED 13 0.0002
229 SWELLING 20 0.0002
230 BLINDNESS UNILATERAL 3 0.0002
231 SKIN ABRASION 1 0.0002
232 POST PROCEDURAL COMPLICATION 4 0.0002
233 HORMONE LEVEL ABNORMAL 1 0.0002
234 PRODUCT COLOUR ISSUE 1 0.0002
235 TRISMUS 1 0.0002
236 PERIORBITAL OEDEMA 1 0.0002
237 PARTIAL SEIZURES 1 0.0002
238 RASH ERYTHEMATOUS 9 0.0002
239 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
240 BRUXISM 1 0.0002
241 HYDROCEPHALUS 1 0.0002
242 PULMONARY THROMBOSIS 2 0.0002
243 ASTHENOPIA 1 0.0002
244 DISCOMFORT 11 0.0002
245 WOUND 5 0.0002
246 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
247 PERIORBITAL SWELLING 1 0.0002
248 SKIN ATROPHY 1 0.0002
249 HYPERVENTILATION 1 0.0002
250 RASH MACULAR 6 0.0002
251 OCULAR HYPERAEMIA 8 0.0002
252 DEVICE ISSUE 15 0.0002
253 TOOTHACHE 3 0.0002
254 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
255 HYPOTENSION 33 0.0002
256 APPLICATION SITE IRRITATION 2 0.0002
257 SCREAMING 1 0.0002
258 HAEMOGLOBIN ABNORMAL 1 0.0002
259 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
260 ADVERSE REACTION 2 0.0002
261 CARDIAC FAILURE ACUTE 1 0.0001
262 MENINGITIS 1 0.0001
263 POSTOPERATIVE WOUND INFECTION 1 0.0001
264 DEVICE BREAKAGE 6 0.0001
265 FEELING HOT 9 0.0001
266 ABNORMAL LOSS OF WEIGHT 1 0.0001
267 ECCHYMOSIS 1 0.0001
268 APPLICATION SITE RASH 2 0.0001
269 HAIR GROWTH ABNORMAL 1 0.0001
270 ORAL DISCOMFORT 2 0.0001
271 DERMATITIS 3 0.0001
272 DEVICE MALFUNCTION 10 0.0001
273 SKIN REACTION 2 0.0001
274 SUBDURAL HAEMATOMA 2 0.0001
275 SKIN CANCER 3 0.0001
276 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
277 VISUAL FIELD DEFECT 1 0.0001
278 PRODUCT DOSE OMISSION 9 0.0001
279 INFLAMMATION 7 0.0001
280 BLINDNESS TRANSIENT 1 0.0001
281 HEPATIC FUNCTION ABNORMAL 5 0.0001
282 PEMPHIGOID 1 0.0001
283 DEVICE FAILURE 2 0.0001
284 HAEMODYNAMIC INSTABILITY 1 0.0001
285 BASAL CELL CARCINOMA 2 0.0001
286 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
287 DISORIENTATION 5 0.0001
288 RENAL CYST 1 0.0001
289 PRESYNCOPE 3 0.0001
290 BACK DISORDER 2 0.0001
291 HYPERAESTHESIA 1 0.0001
292 EYE DISORDER 4 0.0001
293 HEMIPLEGIA 1 0.0001
294 EYE PRURITUS 4 0.0001
295 FACIAL PARALYSIS 1 0.0001
296 DEVICE USE ISSUE 2 0.0001
297 THERAPY INTERRUPTED 8 0.0001
298 LIP DRY 1 0.0001
299 HIDRADENITIS 1 0.0001
300 VISION BLURRED 15 0.0001
301 SKIN DISCOLOURATION 5 0.0001
302 PERSONALITY CHANGE 1 0.0001
303 HEPATIC ENCEPHALOPATHY 1 0.0001
304 ACNE 8 0.0001
305 BLOOD PRESSURE DECREASED 7 0.0001
306 DISEASE RECURRENCE 5 0.0001
307 SINUS BRADYCARDIA 1 0.0001
308 PRODUCT STORAGE ERROR 9 0.0001
309 THROMBOTIC MICROANGIOPATHY 1 0.0001
310 PAIN 63 0.0001
311 PHARYNGEAL SWELLING 1 0.0001
312 HEPATOMEGALY 1 0.0001
313 PRODUCT USE ISSUE 19 0.0001
314 EYELID PTOSIS 1 0.0001
315 INJURY ASSOCIATED WITH DEVICE 2 0.0001
316 PRODUCT PREPARATION ERROR 2 0.0001
317 TEMPERATURE INTOLERANCE 1 0.0001
318 EYE DISCHARGE 1 0.0001
319 DECREASED ACTIVITY 1 0.0001
320 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
321 AMNESIA 6 0.0001
322 PRODUCT DISPENSING ERROR 2 0.0001
323 WOUND INFECTION 1 0.0001
324 STAPHYLOCOCCAL INFECTION 3 0.0001
325 OFF LABEL USE 79 0.0001
326 RASH PAPULAR 2 0.0001
327 MYOCARDIAL ISCHAEMIA 1 0.0001
328 SKIN IRRITATION 4 0.0001
329 EYELID OEDEMA 1 0.0001
330 INJURY 6 0.0001
331 CARDIAC ARREST 7 0.0001
332 BACTERAEMIA 1 0.0001
333 MACULAR DEGENERATION 1 0.0001
334 ACCIDENT 1 0.0001
335 DIABETIC KETOACIDOSIS 2 0.0001
336 CEREBRAL INFARCTION 2 0.0001
337 ILEUS 1 0.0001
338 PEMPHIGUS 1 0.0001
339 THERAPY CESSATION 4 0.0001
340 HAIR TEXTURE ABNORMAL 1 0.0001
341 PAIN OF SKIN 2 0.0001
342 LIMB INJURY 2 0.0001
343 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
344 VISUAL IMPAIRMENT 9 0.0001
345 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
346 HERPES ZOSTER 4 0.0001
347 SEIZURE 8 0.0001
348 ACUTE MYOCARDIAL INFARCTION 2 0.0001
349 SKIN HAEMORRHAGE 1 0.0001
350 PULMONARY MASS 1 0.0001
351 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0001
352 APHASIA 2 0.0001
353 PHARYNGEAL OEDEMA 1 0.0001
354 THERAPY PARTIAL RESPONDER 1 0.0001
355 SWOLLEN TONGUE 2 0.0001
356 BRAIN FOG 1 0.0001
357 PNEUMOTHORAX 1 0.0001
358 ATRIAL FIBRILLATION 6 0.0001
359 IMPAIRED HEALING 2 0.0001
360 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
361 EXPIRED PRODUCT ADMINISTERED 2 0.0001
362 LIP SWELLING 2 0.0001
363 FACE OEDEMA 1 0.0001
364 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
365 HEMIPARESIS 1 0.0001
366 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
367 HEART RATE DECREASED 2 0.0001
368 BRADYCARDIA 3 0.0001
369 TREATMENT NONCOMPLIANCE 3 0.0001
370 UNDERDOSE 4 0.0001
371 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
372 CONJUNCTIVITIS 1 0.0001
373 HYPERSENSITIVITY 10 0.0001
374 DYSGEUSIA 4 0.0001
375 OXYGEN SATURATION DECREASED 3 0.0001
376 ERUCTATION 1 0.0001
377 ORAL HERPES 1 0.0001
378 INCORRECT DOSE ADMINISTERED 11 0.0000
379 CARDIO-RESPIRATORY ARREST 2 0.0000
380 HAEMORRHAGE 5 0.0000
381 EATING DISORDER 1 0.0000
382 LOSS OF CONSCIOUSNESS 6 0.0000
383 IMPAIRED WORK ABILITY 1 0.0000
384 LIVER FUNCTION TEST INCREASED 1 0.0000
385 SEPTIC SHOCK 2 0.0000
386 PRODUCT PRESCRIBING ISSUE 1 0.0000
387 ANGIOEDEMA 2 0.0000
388 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
389 LIVER DISORDER 2 0.0000
390 TACHYCARDIA 4 0.0000
391 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
392 THROAT IRRITATION 2 0.0000
393 CHROMATURIA 1 0.0000
394 PRODUCT AVAILABILITY ISSUE 1 0.0000
395 MUSCLE TWITCHING 1 0.0000
396 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
397 ARRHYTHMIA 2 0.0000
398 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
399 DYSPHAGIA 4 0.0000
400 CONTUSION 4 0.0000
401 NEURALGIA 1 0.0000
402 ALOPECIA 8 0.0000
403 ENCEPHALOPATHY 1 0.0000
404 PNEUMONIA ASPIRATION 1 0.0000
405 HALLUCINATION 3 0.0000
406 HYPOPHAGIA 1 0.0000
407 ANAPHYLACTIC SHOCK 1 0.0000
408 UNRESPONSIVE TO STIMULI 1 0.0000
409 DIPLOPIA 1 0.0000
410 PARAESTHESIA 6 0.0000
411 DRY SKIN 5 0.0000
412 BLOOD BILIRUBIN INCREASED 1 0.0000
413 THROAT TIGHTNESS 1 0.0000
414 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
415 SKIN LESION 1 0.0000
416 ANAPHYLACTIC REACTION 2 0.0000
417 PROCEDURAL PAIN 1 0.0000
418 MEDICATION ERROR 2 0.0000
419 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
420 INTENTIONAL DOSE OMISSION 1 0.0000
421 CONVULSION 2 0.0000
422 HYPERSOMNIA 1 0.0000
423 INFECTION 5 0.0000
424 NEEDLE ISSUE 1 0.0000
425 PRURITUS 13 0.0000
426 CATARACT 2 0.0000
427 IRRITABILITY 2 0.0000
428 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
429 DRUG ADMINISTRATION ERROR 1 0.0000
430 DRUG INTOLERANCE 3 0.0000
431 RHINORRHOEA 2 0.0000
432 BLOOD CREATININE INCREASED 2 0.0000
433 VISUAL ACUITY REDUCED 1 0.0000
434 VIRAL INFECTION 1 0.0000
435 SKIN DISORDER 1 0.0000
436 TYPE 2 DIABETES MELLITUS 1 0.0000
437 ANGER 1 0.0000
438 FLUSHING 3 0.0000
439 HEPATIC ENZYME INCREASED 2 0.0000
440 CHEST DISCOMFORT 3 0.0000
441 DELIRIUM 1 0.0000
442 HYPOXIA 1 0.0000
443 SLEEP DISORDER 2 0.0000
444 LYMPHADENOPATHY 1 0.0000
445 CEREBRAL HAEMORRHAGE 1 0.0000
446 OVERDOSE 6 0.0000
447 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
448 VOMITING 13 0.0000
449 DRUG EFFECT INCOMPLETE 1 0.0000
450 CRYING 1 0.0000
451 PANIC ATTACK 1 0.0000
452 RESPIRATORY FAILURE 2 0.0000
453 ACCIDENTAL OVERDOSE 1 0.0000
454 RESTLESSNESS 1 0.0000
455 CHEST PAIN 5 0.0000
456 EPISTAXIS 2 0.0000
457 DYSARTHRIA 1 0.0000
458 PLASMA CELL MYELOMA 1 0.0000
459 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
460 ABNORMAL BEHAVIOUR 1 0.0000
461 LUNG NEOPLASM MALIGNANT 1 0.0000
462 INFLUENZA LIKE ILLNESS 2 0.0000
463 HYPOACUSIS 1 0.0000
464 PYREXIA 8 0.0000
465 INSOMNIA 6 0.0000
466 PULMONARY OEDEMA 1 0.0000
467 MEMORY IMPAIRMENT 3 0.0000
468 RENAL DISORDER 1 0.0000
469 BLOOD GLUCOSE INCREASED 4 0.0000
470 MULTIPLE SCLEROSIS 1 0.0000
471 FEELING ABNORMAL 5 0.0000
472 SYNCOPE 2 0.0000
473 AGGRESSION 1 0.0000
474 CELLULITIS 1 0.0000
475 ILLNESS 2 0.0000
476 NERVOUSNESS 1 0.0000
477 SPEECH DISORDER 1 0.0000
478 DEPRESSED MOOD 1 0.0000
479 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
480 PLATELET COUNT DECREASED 2 0.0000
481 CONFUSIONAL STATE 3 0.0000
482 OEDEMA 1 0.0000
483 MALAISE 8 0.0000
484 URTICARIA 3 0.0000
485 THROMBOCYTOPENIA 2 0.0000
486 HYPONATRAEMIA 1 0.0000
487 NAUSEA 14 0.0000
488 FLATULENCE 1 0.0000
489 HEADACHE 11 0.0000
490 LETHARGY 1 0.0000
491 CHILLS 2 0.0000
492 NASAL CONGESTION 1 0.0000
493 SUICIDE ATTEMPT 1 0.0000
494 ILL-DEFINED DISORDER 1 0.0000
495 CONDITION AGGRAVATED 5 0.0000
496 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
497 INTENTIONAL OVERDOSE 1 0.0000
498 DEEP VEIN THROMBOSIS 1 0.0000
499 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
500 DIZZINESS 7 0.0000
501 RASH 6 0.0000
502 HOT FLUSH 1 0.0000
503 UNEVALUABLE EVENT 1 0.0000
504 BLOOD PRESSURE INCREASED 2 0.0000
505 PNEUMONIA 4 0.0000
506 TREMOR 2 0.0000
507 BALANCE DISORDER 1 0.0000
508 MYOCARDIAL INFARCTION 2 0.0000
509 INTENTIONAL PRODUCT MISUSE 1 0.0000
510 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
511 DRUG WITHDRAWAL SYNDROME 1 0.0000
512 ADVERSE DRUG REACTION 1 0.0000
513 ADVERSE EVENT 1 0.0000
514 OROPHARYNGEAL PAIN 1 0.0000
515 NEUROPATHY PERIPHERAL 1 0.0000
516 MIGRAINE 1 0.0000
517 FATIGUE 8 0.0000
518 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
519 INFLUENZA 1 0.0000
520 SEPSIS 1 0.0000
521 MUSCULAR WEAKNESS 1 0.0000
522 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
523 PALPITATIONS 1 0.0000
524 JOINT SWELLING 1 0.0000
525 EMOTIONAL DISTRESS 1 0.0000
526 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
527 HYPERHIDROSIS 1 0.0000
528 PSORIASIS 1 0.0000
529 RENAL FAILURE 1 0.0000
530 DEHYDRATION 1 0.0000
531 DYSPNOEA 4 0.0000
532 ANXIETY 2 0.0000
533 ACUTE KIDNEY INJURY 1 0.0000
534 FALL 2 0.0000
535 ABDOMINAL DISCOMFORT 1 0.0000
536 CEREBROVASCULAR ACCIDENT 1 0.0000
537 URINARY TRACT INFECTION 1 0.0000
538 NO ADVERSE EVENT 1 0.0000
539 MUSCLE SPASMS 1 0.0000
540 NASOPHARYNGITIS 1 0.0000
541 ASTHENIA 2 0.0000
542 ANAEMIA 1 0.0000
543 GAIT DISTURBANCE 1 0.0000
544 SOMNOLENCE 1 0.0000
545 ABDOMINAL PAIN UPPER 1 0.0000
546 WEIGHT INCREASED 1 0.0000
547 DECREASED APPETITE 1 0.0000
548 BACK PAIN 1 0.0000
549 WEIGHT DECREASED 1 0.0000
550 PAIN IN EXTREMITY 1 0.0000
551 INJECTION SITE PAIN 1 0.0000
552 ARTHRALGIA 1 0.0000
553 DEATH 1 0.0000